Graphene-based fluorescent materials, particularly graphene quantum dots (GQDs), have emerged as a new class of biomedical agents. In the present study, functionalised GQDs have a better chance of being employed in a broader range of bioapplications because of their proven low toxicity, outstanding biocompatibility, and enhanced fluorescence properties. For this purpose, amino-functionalised GQDs (AF-GQDs) were synthesised via hydrothermal treatment by treating graphene oxide in ammonia with heat and water. The as-prepared AF-GQDs samples were characterised using a variety of techniques, including x-ray diffraction analysis (XRD), high-resolution transmission electron microscopy (HR-TEM), and photoluminescence (PL) spectroscopy. The results show that AF-GQDs are merely hexagonal, with an average size of about 8 nm. Also, AF-GQDs are highly soluble in water and display excellent luminescence behaviour. After 48 h of incubation, the MTT results showed that more than 63% of the cells were still alive, even at high concentrations (500 g ml −1 ) of AF-GQDs. In addition, the AO/EB staining results also showed that the AF-GQDs had the most robust green fluorescence (viable cells). This makes them a promising agent for biomedical imaging because they have good optical properties, are readily soluble in water, are biocompatible, and are not toxic.
No takes yet. Share an insight, caveat, or question.
Anjusha et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: